Tear trough filler is one of the most frequently searched aesthetic procedures — and one of the areas where injector experience matters most. The skin under the eye is the thinnest on the face (about 0.5 mm), the vascular anatomy is complex, and the margin between a good result and a visible complication is narrow.
This article covers what tear trough filler actually costs, what drives the price, the specific risks that distinguish this area from other filler sites, and how to evaluate whether a provider's pricing reflects the skill the area demands.
What tear trough filler costs in the US
Tear trough filler is priced per syringe. According to the American Society of Plastic Surgeons, the national average cost of a hyaluronic acid filler syringe is $684. In practice, most patients pay between $650 and $1,500 per syringe, with the total cost for both eyes typically falling between $1,000 and $2,000.
Most patients need one syringe for both eyes (0.5 mL per side) if the hollows are shallow, or one syringe per eye if the hollows are deeper. The total volume is usually small — a retrospective study published in the Journal of Clinical and Aesthetic Dermatology found that the average volume injected per infraorbital hollow was 0.45 mL.
| Factor | Typical range |
|---|---|
| Cost per syringe | $650–$1,500 |
| Syringes needed | 1–2 total (both eyes) |
| Total cost (both eyes) | $1,000–$2,000 |
| Duration of results | 9–18 months |
| Maintenance | Once yearly, sometimes less |
What the price should include
A quoted price per syringe should cover the filler product itself, the injection procedure, aftercare instructions, and a follow-up appointment. If a follow-up is not included, ask why. The under-eye area is unforgiving — overcorrection, lumps, and Tyndall effect (a bluish discoloration from superficial placement) are more visible here than almost anywhere else on the face.
Why the range is so wide
Geography accounts for some of the spread. Metropolitan practices charge more than suburban or rural clinics. But the larger driver is injector expertise. Providers with specialized training in periocular anatomy — oculoplastic surgeons, facial plastic surgeons, and board-certified dermatologists who focus on the eye area — tend to charge more because the complication rate in their hands is lower and the aesthetic results are more predictable.
A price at the low end of the range is not automatically a red flag. But a price significantly below the average, especially from a provider without board certification or specific periocular training, should prompt questions about experience, not just cost.
The products used under the eye
Not all hyaluronic acid fillers behave the same way in the tear trough. The under-eye area requires a soft, low-G-prime filler that integrates smoothly with the thin skin and does not attract excessive water.
Common products used in the tear trough include:
- Restylane-L and Restylane Eyelight — NASHA-technology fillers with firm gel properties that resist water absorption. Restylane Eyelight is FDA-approved for infraorbital hollows and has shown 87% of patients with reduced hollowness at three months in clinical studies, with results lasting up to 18 months.
- Juvéderm Volbella XC — A Vycross-technology filler that was the first dermal filler FDA-approved specifically for infraorbital hollows (February 2022). Its smooth, cohesive gel is designed to provide subtle hydration and volume with minimal puffiness.
- Belotero Balance — A low-G-prime filler that integrates well in the superficial dermis, sometimes used for fine under-eye lines.
The specific product matters because high-G-prime fillers (designed for cheek projection) placed in the tear trough can create visible ridges, prolonged swelling, or Tyndall effect. A provider who discusses product choice in terms of your anatomy, not just what they have in stock, is making a clinically appropriate decision.
Needle vs. cannula
Tear trough filler can be injected with a sharp needle or a blunt-tipped cannula. Each has tradeoffs:
- Cannula — Lower risk of intravascular injection because the blunt tip is less likely to penetrate vessel walls. May be associated with slightly more post-procedure edema. Most experienced periocular injectors prefer cannulas for this area.
- Needle — Allows more precise placement but carries a higher risk of ecchymosis (bruising) and, in theory, higher vascular risk. Some providers use needles for specific techniques, such as serial puncture along the orbital rim.
A retrospective study of 155 tear trough filler patients found that 82% of treatments were performed with a 27-gauge cannula, and most patients saw improvement sustained at 18 months. No standard guideline mandates one technique over the other, but the choice should reflect the injector's comfort and the patient's anatomy.
The risks that distinguish tear trough filler
All filler procedures carry common risks: bruising, swelling, asymmetry, infection, and allergic reaction. The tear trough area adds specific concerns that are less common or less severe in other facial areas.
Vascular occlusion and vision risk
The angular artery and its branches run through the tear trough region. If filler is inadvertently injected into a vessel, it can block blood flow (vascular occlusion), leading to tissue necrosis. In rare cases, filler material can travel retrograde through the ophthalmic artery system to the central retinal artery, causing permanent vision loss.
The nose, glabella, and forehead are the most commonly reported sites for filler-induced blindness. A review in the Journal of Cosmetic Dermatology identified 60 published cases of HA-filler-related vision loss, with no reports specifically from tear trough injection — but the theoretical risk exists because of vascular anastomoses in the periocular region.
The FDA issued a safety communication on dermal filler injection into facial blood vessels and requires that labeling address the risk of unintentional intravascular injection, including vision impairment, blindness, and tissue necrosis.
Warning signs of vascular occlusion include sudden severe pain, skin blanching or color changes, and tissue breakdown. If these occur, immediate injection of hyaluronidase is the standard first response. The treatment window for central retinal artery occlusion is estimated at 60–90 minutes.
Tyndall effect and superficial placement
When filler is placed too superficially in the thin under-eye skin, light scatters off the gel particles, creating a bluish tint. This is the Tyndall effect, and it can persist until the filler dissolves or is removed with hyaluronidase. It is one of the most common aesthetic complications in this area and is almost entirely technique-dependent.
Persistent edema and malar bags
Filler can impair lymphatic drainage in the under-eye and midface area, leading to chronic puffiness or malar edema. This is more common in patients who already have poor tissue elasticity or fluid retention tendencies. In some cases, retained HA filler can persist for years beyond the expected degradation time, appearing as soft-tissue fullness that mimics fat herniation.
Moorfields Eye Hospital has noted that filler material can persist and migrate years after injection, and that patients who later pursue eyelid surgery may face complications from scarring and tissue distortion caused by prior filler.
Delayed nodules
Palpable or visible nodules can appear weeks to months after injection. These may result from uneven product distribution, inflammatory reactions, or biofilm formation. The risk increases with repeated treatments over time.
Who is and is not a candidate
Tear trough filler works best for patients with true volume deficiency — a deep crease between the lower eyelid and upper cheek that creates a shadow. It does not correct pigmentation-based dark circles, though it may reduce shadow-driven discoloration.
Good candidates tend to have:
- Clear volume loss or hollowing in the tear trough
- Reasonably thick skin that will hide the filler
- No significant lower eyelid fat herniation (bags)
- No active inflammatory skin conditions near the injection site
Poor candidates include patients with prominent under-eye bags, very thin or crepey skin, significant malar edema, or expectations that filler will correct pigmentation or excess skin. In these cases, surgical options like lower blepharoplasty or skin treatments may be more appropriate.
What to ask before booking
The questions below address the specific risks of the tear trough area:
- What is your training in periocular anatomy? Oculoplastic surgeons, facial plastic surgeons, and dermatologists with specific eye-area experience have the deepest anatomical knowledge for this zone.
- Do you use cannula or needle, and why? The answer should reflect your anatomy, not just the provider's habit.
- Which product do you use for tear troughs, and why? A provider who names a low-G-prime HA filler and explains the reasoning is making a deliberate choice.
- What is your protocol for vascular occlusion? Every provider who injects fillers should have hyaluronidase on hand and a plan for emergency management.
- What happens if I do not like the result? HA fillers can be dissolved with hyaluronidase. If a provider cannot or will not discuss reversal, that is a concern.
- Will you assess my baseline vision? Some oculoplastic surgeons document baseline visual acuity before periocular filler. This is good practice but not yet universal.
Maintenance cost over time
Tear trough filler typically lasts 9–18 months, depending on the product and the individual. Over five years, maintenance costs can add up:
| Year | Estimated cost |
|---|---|
| Year 1 (initial treatment) | $1,000–$2,000 |
| Years 2–5 (maintenance, once yearly) | $700–$1,500/year |
| 5-year total | $3,800–$8,000 |
This is a recurring cost, and patients who are not prepared for the financial commitment may find themselves choosing between maintenance and letting the results fade unevenly.
Cheek support as an alternative or complement
Some providers recommend starting with midface or cheek filler rather than injecting directly into the tear trough. The logic: cheek volume loss contributes to tear trough depth. Restoring cheek support can lift and smooth the under-eye area without placing filler in the thin, high-risk tear trough skin itself.
This approach may cost more initially (2–3 syringes of a firmer product like Juvéderm Voluma for the cheeks, at $1,300–$2,400 total) but carries a different risk profile and may produce more natural, longer-lasting results. Some patients benefit from both: cheek filler for structural support and a small amount of tear trough filler for fine contouring.
What low pricing can omit
A price at the bottom of the range may reflect:
- Use of a non-premium or off-label filler not designed for the tear trough area
- No follow-up appointment included
- Provider without board certification or specific periocular training
- No hyaluronidase on hand for emergency reversal
- High-volume, short-appointment practice model with limited individualized assessment
The cost of treating a complication (hyaluronidase injections, surgical revision, emergency ophthalmology referral) can far exceed the savings from choosing the cheapest provider.
Sources
- American Society of Plastic Surgeons. Dermal Fillers: Average Cost. https://www.plasticsurgery.org/cosmetic-procedures/dermal-fillers/cost
- Sharad J. Long-Term Effects of Tear Trough Hyaluronic Acid Filler: A Retrospective Study. Journal of Clinical and Aesthetic Dermatology. https://jcadonline.com/long-term-effects-of-tear-trough-hyaluronic-acid-filler-a-retrospective-study
- U.S. Food and Drug Administration. FDA Safety Communication: Unintentional Injection of Soft Tissue Filler into Blood Vessels in the Face. https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/fda-warns-about-risk-unintentional-injection-soft-tissue-filler-face
- Beleznay K et al. Avoiding and Treating Blindness From Fillers: A Review of the World Literature. Dermatologic Surgery. https://pmc.ncbi.nlm.nih.gov/articles/PMC8294333
- Hartstein M, Massry G. Complications after Cosmetic Periocular Filler: Prevention and Management. Ophthalmic Plastic and Reconstructive Surgery. https://www.oaepublish.com/articles/2347-9264.2020.133
- Moorfields Eye Hospital Private. The 5 Key Risks of Under-Eye Filler Injections. https://moorfields.nhs.uk/private/about-moorfields-private/blog-articles/the-5-key-risks-of-under-eye-filler-injections
- Narukar V et al. Dermal Fillers for the Treatment of Tear Trough Deformity: A Review of Anatomy, Treatment Techniques, and Outcomes. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC3560162
- American Academy of Ophthalmology. Treating Tear Trough Deformities With Dermal Fillers. https://www.aao.org/eyenet/article/treating-tear-trough-deformities-with-dermal-fille
